In Silico Structural Analysis Predicting the Pathogenicity of PLP1 Mutations in Multiple Sclerosis

Area of Science:

• Neuroscience
• Genetics
• Computational Biology

Background:

• The X chromosome gene PLP1 encodes myelin proteolipid protein (PLP), crucial for central nervous system myelin.
• X-linked dysmyelinating disorders like Pelizaeus-Merzbacher disease (PMD) and spastic paraplegia type 2 (SPG2) arise from PLP1 mutations.
• Some PLP1 missense mutations present symptoms overlapping with multiple sclerosis (MS), a chronic neurological disease.

Purpose of the Study:

• To investigate the impact of PLP1 mutations on PLP structure and function.
• To explore the potential role of PLP1 mutations in the pathogenicity of multiple sclerosis (MS).
• To identify potential therapeutic targets for MS based on PLP1 mutation effects.

Main Methods:

• Computational structural biology methods were employed to analyze PLP structure stability and flexibility.
• In silico genomic methods were used to predict the functional significance of PLP1 mutations.
• Analysis focused on missense mutations identified in individuals with MS-like symptoms.

Main Results:

• PLP1 variants were found to significantly alter protein structure and function.
• Specific mutations, such as R137W, can lead to loss of helical structure.
• The H140Y mutation was observed to disrupt the ordered protein interface, affecting protein interactions.

Conclusions:

• PLP1 mutations can impair myelin proteolipid protein functionality, potentially contributing to MS.
• Computational analyses provide insights into the molecular mechanisms underlying PLP1-associated neurological disorders.
• Findings may inform the development of targeted therapeutic strategies for MS patients with specific genetic profiles.